Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.
作者信息
Colquhoun D
机构信息
University College London.
出版信息
Br J Pharmacol. 1998 Nov;125(5):924-47. doi: 10.1038/sj.bjp.0702164.
Abstract
摘要
相似文献
1
Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.结合、门控、亲和力与效能：激动剂的构效关系解读及受体突变效应
Br J Pharmacol. 1998 Nov;125(5):924-47. doi: 10.1038/sj.bjp.0702164.
2
Taking the time to study competitive antagonism.花时间研究竞争性拮抗作用。
Br J Pharmacol. 2007 Mar;150(5):541-51. doi: 10.1038/sj.bjp.0706997. Epub 2007 Jan 22.
3
A mutation that alters magnesium block of N-methyl-D-aspartate receptor channels.一种改变N-甲基-D-天冬氨酸受体通道镁离子阻滞作用的突变。
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9259-63. doi: 10.1073/pnas.93.17.9259.
4
Different structural requirements for functional ion pore transplantation suggest different gating mechanisms of NMDA and kainate receptors.功能性离子通道移植的不同结构要求表明NMDA受体和海人酸受体具有不同的门控机制。
J Neurochem. 2008 Oct;107(2):453-65. doi: 10.1111/j.1471-4159.2008.05623.x. Epub 2008 Aug 14.
5
Gain of function mutants: ion channels and G protein-coupled receptors.功能获得性突变体：离子通道和G蛋白偶联受体。
Annu Rev Neurosci. 2000;23:89-125. doi: 10.1146/annurev.neuro.23.1.89.
6
Receptor-regulated ion channels.受体调控离子通道
Curr Opin Cell Biol. 1997 Apr;9(2):155-60. doi: 10.1016/s0955-0674(97)80057-9.
7
Markov modeling of allosteric drug effects on ion channels, with particular reference to neuronal nicotinic acetylcholine receptors.变构药物对离子通道作用的马尔可夫模型，特别涉及神经元烟碱型乙酰胆碱受体。
Arch Biochem Biophys. 2000 Jan 15;373(2):429-34. doi: 10.1006/abbi.1999.1571.
8
Mutational analysis of G-protein coupled receptor--FFA2.G 蛋白偶联受体--FFA2 的突变分析。
Biochem Biophys Res Commun. 2011 Feb 4;405(1):122-7. doi: 10.1016/j.bbrc.2010.12.139. Epub 2011 Jan 7.
9
Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel.与离子通道相连的乙酰胆碱结合蛋白中激动剂结合与通道门控的偶联。
Nature. 2004 Aug 19;430(7002):896-900. doi: 10.1038/nature02753.
10
The neuroreceptors: one key for many locks.神经受体：一把钥匙开多把锁。
J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):161-72. doi: 10.3109/10799899509045214.
引用本文的文献
1
From IP3RPEP6 Inhibition of IP receptor channels to insights: do channel subunits collaborate or cooperate?从IP3RPEP6对IP受体通道的抑制到见解：通道亚基是协同还是合作？
Cell Mol Life Sci. 2025 Jul 19;82(1):285. doi: 10.1007/s00018-025-05813-7.
2
The flexibility of SABRE, a new quantitative receptor function model, when fitting challenging concentration-effect data.新型定量受体功能模型SABRE在拟合具有挑战性的浓度-效应数据时的灵活性。
Front Pharmacol. 2025 Jun 12;16:1591761. doi: 10.3389/fphar.2025.1591761. eCollection 2025.
3
Quantification of signal amplification for receptors: the /EC ratio of full agonists as a gain parameter.受体信号放大的定量分析：以完全激动剂的/EC比值作为增益参数。
Front Pharmacol. 2025 Apr 8;16:1541872. doi: 10.3389/fphar.2025.1541872. eCollection 2025.
4
Preferential allosteric modulation of Otop1 channels by small molecule compounds.小分子化合物对Otop1通道的选择性变构调节
Commun Biol. 2025 Feb 26;8(1):314. doi: 10.1038/s42003-025-07775-9.
5
A propofol binding site in the voltage sensor domain mediates inhibition of HCN1 channel activity.电压传感器结构域中的异丙酚结合位点介导对HCN1通道活性的抑制。
Sci Adv. 2025 Jan 3;11(1):eadr7427. doi: 10.1126/sciadv.adr7427.
6
Ligand-coupled conformational changes in a cyclic nucleotide-gated ion channel revealed by time-resolved transition metal ion FRET.时间分辨过渡金属离子荧光共振能量转移揭示的环核苷酸门控离子通道中配体偶联的构象变化
Elife. 2024 Dec 10;13:RP99854. doi: 10.7554/eLife.99854.
7
Mechanisms of Action Underlying Conductance-Modifying Positive Allosteric Modulators of the NMDA Receptor.作用于 NMDA 受体的变构正调节剂的作用机制。
Mol Pharmacol. 2024 Nov 18;106(6):334-353. doi: 10.1124/molpharm.124.001019.
8
Ligand-Coupled Conformational Changes in a Cyclic Nucleotide-Gated Ion Channel Revealed by Time-Resolved Transition Metal Ion FRET.时间分辨过渡金属离子荧光共振能量转移揭示的环核苷酸门控离子通道中的配体偶联构象变化
bioRxiv. 2024 Oct 2:2024.04.25.591185. doi: 10.1101/2024.04.25.591185.
9
Exploring the Activation Process of the Glycine Receptor.探索甘氨酸受体的激活过程。
J Am Chem Soc. 2024 Sep 25;146(38):26297-26312. doi: 10.1021/jacs.4c08489. Epub 2024 Sep 16.
10
Allosteric inhibition of CFTR gating by CFTRinh-172 binding in the pore.变构抑制 CFTR 门控由 CFTRinh-172 在孔中的结合。
Nat Commun. 2024 Aug 6;15(1):6668. doi: 10.1038/s41467-024-50641-1.
Zotero 插件